Product NDC: | 0049-0022 |
Proprietary Name: | UNASYN |
Non Proprietary Name: | AMPICILLIN SODIUM and SULBACTAM SODIUM |
Active Ingredient(s): | 1; .5 g/1; g/1 & nbsp; AMPICILLIN SODIUM and SULBACTAM SODIUM |
Administration Route(s): | INTRAMUSCULAR; INTRAVENOUS |
Dosage Form(s): | INJECTION, POWDER, FOR SOLUTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0049-0022 |
Labeler Name: | Roerig |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA050608 |
Marketing Category: | NDA |
Start Marketing Date: | 19911122 |
Package NDC: | 0049-0022-83 |
Package Description: | 1 INJECTION, POWDER, FOR SOLUTION in 1 BOTTLE (0049-0022-83) |
NDC Code | 0049-0022-83 |
Proprietary Name | UNASYN |
Package Description | 1 INJECTION, POWDER, FOR SOLUTION in 1 BOTTLE (0049-0022-83) |
Product NDC | 0049-0022 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | AMPICILLIN SODIUM and SULBACTAM SODIUM |
Dosage Form Name | INJECTION, POWDER, FOR SOLUTION |
Route Name | INTRAMUSCULAR; INTRAVENOUS |
Start Marketing Date | 19911122 |
Marketing Category Name | NDA |
Labeler Name | Roerig |
Substance Name | AMPICILLIN SODIUM; SULBACTAM SODIUM |
Strength Number | 1; .5 |
Strength Unit | g/1; g/1 |
Pharmaceutical Classes | Penicillin-class Antibacterial [EPC],Penicillins [Chemical/Ingredient],beta Lactamase Inhibitors [MoA],beta Lactamase Inhibitor [EPC] |